Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Oestrogens are key for bone growth during puberty in both boys and girls.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Blocking β-catenin in skin cells improves hair growth during wound healing.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Baricitinib is effective and safe for treating severe alopecia areata.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

PRP injections may improve skin texture and wrinkles based on patient feedback, despite no significant changes seen by dermatologists.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Minoxidil effectively treats female pattern hair loss.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Micropigmentation safely and effectively hides scalp hair loss and scars.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.